Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Coocooburra's Profile
Displaying 1-50 of 404 result(s).
CYDY CytoDyn Inc
08/23/2020 1:45:15 PM
Its here https://www.forbes.com/sit (1)
CYDY CytoDyn Inc
08/07/2020 9:01:21 AM
Really ppl what a useless post. (4)
CYDY CytoDyn Inc
08/05/2020 4:11:44 PM
It is and it isn't a competition. W (2)
CYDY CytoDyn Inc
08/05/2020 2:46:48 PM
I would vote heavily in favor of so (1)
CYDY CytoDyn Inc
08/05/2020 2:29:33 PM
Lenzilumab changed primary endpoint (9)
CYDY CytoDyn Inc
08/04/2020 11:16:32 PM
rlftf phase 2/3 PR. From July. Thei (3)
CYDY CytoDyn Inc
08/04/2020 6:33:56 PM
Ok so they evaluated 14 day endpoin
CYDY CytoDyn Inc
08/04/2020 6:02:27 PM
Could you clarify? I'm sorry but I
CYDY CytoDyn Inc
08/04/2020 12:31:20 PM
Yeah I'm just not seeing a whole lo (3)
CYDY CytoDyn Inc
08/04/2020 11:37:08 AM
Yeah i was on the cc yesterday and (2)
CYDY CytoDyn Inc
08/01/2020 5:10:46 PM
Mortality rate for all eIND patient
CYDY CytoDyn Inc
08/01/2020 2:24:07 PM
Per Dr. P last night, cydy has tens (3)
CYDY CytoDyn Inc
08/01/2020 11:31:59 AM
Last Q asked Dr P last night was ba (5)
CYDY CytoDyn Inc
07/30/2020 8:48:05 PM
What type of narrative can we devel (12)
CYDY CytoDyn Inc
07/30/2020 8:44:15 PM
Correction - Oxygen use and Mech ve (3)
CYDY CytoDyn Inc
07/30/2020 8:12:28 PM
Re-listened to m2m update - Day 3 v (4)
CYDY CytoDyn Inc
07/30/2020 11:47:39 AM
covid cases at all time high in USA (13)
CYDY CytoDyn Inc
07/30/2020 8:55:30 AM
Financing news closes us above 5. A (4)
CYDY CytoDyn Inc
07/29/2020 9:36:05 PM
Meso interim scheduled for Septembe (1)
CYDY CytoDyn Inc
07/23/2020 10:14:55 AM
Will post my complete analysis on S (6)
CYDY CytoDyn Inc
07/23/2020 10:04:26 AM
5/56 experienced SAE in treatment. (11)
CYDY CytoDyn Inc
07/18/2020 10:15:45 AM
Grateful to all the longs here. Hav (11)
CYDY CytoDyn Inc
07/14/2020 8:59:01 AM
Leronlimab doesn't block any virus (1)
CYDY CytoDyn Inc
07/06/2020 6:11:06 PM
so my assumption then is that the a
CYDY CytoDyn Inc
07/06/2020 5:02:57 PM
Can you elaborate? I personally hav
CYDY CytoDyn Inc
07/06/2020 12:08:24 PM
they are not delaying the m2m resul (4)
CYDY CytoDyn Inc
07/06/2020 10:14:29 AM
Doesn't matter as much as it might'
CYDY CytoDyn Inc
07/05/2020 3:59:25 PM
Yes I agree with you on the results (5)
CYDY CytoDyn Inc
07/05/2020 3:06:48 PM
This is gonna be a crazy ass month (3)
CYDY CytoDyn Inc
07/05/2020 3:06:00 PM
In my mind the publication or submi (2)
CYDY CytoDyn Inc
07/05/2020 1:01:32 PM
Yes I meant to say interim for s/c
CYDY CytoDyn Inc
07/05/2020 12:47:56 PM
I had email exchange with NP which (7)
CYDY CytoDyn Inc
07/04/2020 8:04:43 PM
No actemra failed in Italian study
CYDY CytoDyn Inc
07/04/2020 3:07:10 PM
this study is more definitive than (2)
CYDY CytoDyn Inc
07/04/2020 3:03:19 PM
WHO discontinues hydroxychloroquin (2)
CYDY CytoDyn Inc
07/04/2020 9:44:42 AM
The baricitinib /rem trial is categ
CYDY CytoDyn Inc
07/04/2020 8:52:22 AM
From PR Advised the Company, subjec (1)
CYDY CytoDyn Inc
07/03/2020 8:43:36 PM
Guys my bad Leronlimab is on the li
CYDY CytoDyn Inc
07/03/2020 8:19:40 PM
Mavrilimumab Lenzilumab Anakinra Ca (3)
CYDY CytoDyn Inc
07/03/2020 9:44:42 AM
Outcomes for UCLA + other hospital (1)
CYDY CytoDyn Inc
07/03/2020 9:12:18 AM
~15 mortality
CYDY CytoDyn Inc
07/03/2020 9:11:21 AM
~15%
CYDY CytoDyn Inc
07/02/2020 6:48:05 PM
Just my guess - Our m2m p value wil (11)
CYDY CytoDyn Inc
07/01/2020 12:41:56 PM
Anything about interim at work can'
CYDY CytoDyn Inc
07/01/2020 10:32:16 AM
They must know interim results by n
CYDY CytoDyn Inc
06/30/2020 8:58:33 PM
Marked it as an announcement on FB (1)
CYDY CytoDyn Inc
06/29/2020 12:44:08 PM
Sorry I'm trying to put together th
CYDY CytoDyn Inc
06/29/2020 12:12:32 PM
Can you elaborate a little more on
CYDY CytoDyn Inc
06/25/2020 10:31:29 AM
What is happening???? (2)
CYDY CytoDyn Inc
06/25/2020 9:43:22 AM
Idk anything but is this daily incr
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch benzingaheadline@gmail.com. Target readers who trust our platform to stay ahead of the curve.

Recent Articles

  • Transforming Automotive Innovation with SDV Accelerator from AWS and HERE
  • Sutter Health's Innovative Approaches to Healthcare Excellence
  • USANA Unveils New Nutrition Products for Vibrant Living
  • Modeyso™ Receives NCCN Recommendations for Rare Brain Cancer
  • Projected Growth of Clinical Nutrition Market to 49.04 Billion
  • Exciting Times Ahead as MetaOptics Ltd Impresses Investors
  • Exploring the Surge of the Cell Lysis and Disruption Market
  • Transforming Workplace Safety: Hearing Protection Innovations
  • Toobit Launches Exciting $35,000 Trading Competition Event
  • Dataprana Teams Up with MicroBT for $5 Million Mining Project
  • ReconAfrica Expands in Gabon with New Production Sharing Contract
  • FactSet Integrates AI-Enhanced MarketAxess CP+ Data into Workstation
  • Bowman Consulting Strengthens Partnership with Nebraska DOT
  • Caliber Enhances Digital Asset Strategy with Chainlink Tokens
  • Major Find at Caniapisc Au Project: Midland's Recent Discoveries
  • Breakthrough Cognitive Results for Blarcamesine in Alzheimer's Treatment
  • Bombardier's Exceptional Performance Recognized with TSX30 Honor
  • Dragonfly Energy Partners with Ember for Advanced RV Power Solutions
  • Donald Trump Jr. Enhances MMA.INC's Growth as Advisor
  • Compass Lexecon Welcomes Three Renowned Economic Experts
  • Aveanna Healthcare Gears Up for Jefferies Conference in Nashville
  • Stardust Power Advances Lithium Refinery Project with FEL 3 Report
  • Key Insights on Apax Global Alpha Limited's Recent Disclosure
  • Rathbones Group Plc's Key Regulatory Disclosure Overview
  • Sprott's Platinum and Palladium Trust Launches Enhanced Equity Program
  • Comprehensive Disclosure Update by Rathbones Group Plc
  • Treatt PLC Disclosure Highlights Investor Interests
  • Understanding Public Disclosures in the Life Science Sector
  • Bowman Consulting Expands Reach with Nebraska Bridge Project
  • Portillo’s Reveals Upcoming Management Fireside Chat Details
  • Caliber Advances Digital Asset Portfolio with Chainlink Tokens
  • Dataprana Partners with MicroBT to Boost Mining Capacity
  • RingConn Advances Health Tech with New Blood Pressure Insights
  • Emergent BioSolutions Secures Major Contract for Vaccine Supply
  • New Gold Celebrates TSX30 Ranking for Exceptional Growth
  • Colliers Expands Multifamily Services Through Strategic Acquisition
  • Grubhub Holdings Unveils Results from Recent Exchange Offer
  • Aveanna Healthcare Prepares for Jefferies Conference in Nashville
  • Jack Azagury Takes Leadership Role at BRG Consulting Firm
  • Symmetry Partners Unveils Innovative ETF for Investors
  • Sapiens Introduces 13.0 CoreSuite for Insurance Enhancements
  • Pan Global Resources Hits High-Grade Gold in Latest Drills
  • Celebrating 11 Years of V2X's Automotive Technician Program
  • Fidelity National Financial Teams Up with CLEAR to Counteract Fraud
  • New Leadership: Silvère Lucquin Joins Okomera as CEO
  • Conagra Brands Foundation Funding Empowers Local Nonprofits
  • Broadridge's Strategic Acquisition of iJoin Elevates Retirement Solutions
  • CRYOVAC® Achieves Milestone with 4,000th Packaging System
  • Analog Pharma Canada Unveils First Product for Maternal Health
  • Electra Welcomes Admiral Hueber to Strengthen Board Leadership
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site